Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$46,761,464
-$171,260 QoQ
Shares Held
184,122
-4.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#459
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $269,326,033 across 9 Drug Manufacturers - General names. JNJ ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
40,766 | $48,895,967 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
184,122 | $46,761,464 | |
| 3 | ABBV |
AbbVie Inc.
|
160,685 | $40,434,773 | |
| 4 | MRK |
Merck & Co., Inc.
|
274,491 | $35,272,093 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
520,919 | $30,015,352 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
181,879 | $22,978,592 | |
| 7 | AMGN |
Amgen Inc
|
62,656 | $22,688,990 | |
| 8 | PFE |
Pfizer Inc
|
477,198 | $11,490,927 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,761,464 | 184,122 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $46,932,724 | 192,001 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $47,062,499 | 227,410 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $43,892,622 | 236,720 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $39,451,200 | 258,273 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $42,486,715 | 256,191 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $39,820,103 | 275,343 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $46,006,888 | 283,888 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $48,167,319 | 329,552 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $54,935,115 | 347,273 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $57,080,005 | 364,170 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $59,466,128 | 381,805 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $65,629,506 | 396,505 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $64,095,755 | 413,521 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $72,209,573 | 408,772 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $73,749,851 | 451,456 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $82,016,897 | 462,041 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $91,683,027 | 517,311 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $98,009,253 | 572,919 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $97,262,729 | 602,246 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $116,342,352 | 706,218 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $121,939,153 | 741,948 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $114,018,347 | 724,478 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $99,925,129 | 671,179 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $94,148,268 | 669,475 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $86,603,496 | 660,440 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||